Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ranitidine Cancer Risk Found Only By Litigation Plaintiffs’ ‘Unreliable’ Research, Judge Rules

Dec 15 2022

• By Lauren Nardella

• Source: Shutterstock

Related Content

Sanofi Returning Zantac OTC Heartburn Remedy Brand To US Market Formulated With Famotidine

Apr 28 2021

Valisure’s Benzene Testing Challenged By PCPC; FDA Focus Should Be Raw Materials, Trade Group Says

Dec 06 2022

US FDA Requests Ranitidine Removal But Also Encourages Research For Stable Formulations

Apr 02 2020

Online Pharmacy Stirs Ranitidine Controversy With Petition To Halt Sales

Sep 15 2019

Ranitidine Litigation Opens With Settlements, But Still Massive With State And MDL Trials Pending

Aug 19 2022

Related Companies

Sanofi

Additional Topics

International United States US States Legal Issues OTC Drugs Safety Advertising, Marketing & Sales Business Strategies Commercial Companies Compliance Consumer Distribution Drug Approval Standards Drug Safety FDA Ingredients Manufacturing Policy Regulation Retail Research & Development

More from International

More from Geography

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window